NCT00160225View on ClinicalTrials.gov

Study to Evaluate the Efficacy and Safety of Daglutril Compared to Placebo on Top of Losartan in Type 2 Diabetics With Overt Nephropathy and Well Controlled Hypertension

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 2005

Conditions
Hypertension
Interventions
DRUG

Daglutril

Trial Locations (1)

Unknown

Site 1, Ranica

All Listed Sponsors
lead

Solvay Pharmaceuticals

INDUSTRY

NCT00160225 - Study to Evaluate the Efficacy and Safety of Daglutril Compared to Placebo on Top of Losartan in Type 2 Diabetics With Overt Nephropathy and Well Controlled Hypertension | Biotech Hunter | Biotech Hunter